Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Leukemia
Leukemia
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Read More
Leukemia
Brentuximab Cost-Effective After Transplant
Read More
Leukemia
Pediatric Regimen a New Standard for Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Read More
Leukemia
CAR-T Achieves High Rate of Remission in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia
Read More
Leukemia
Sorafenib Prolongs Event- and Relapse-Free Survival in Acute Myeloid Leukemia
Read More
Leukemia
Pracinostat-Azacitidine Combination Generates Responses in Older Adults with Acute Myeloid Leukemia
Read More
Leukemia
Psychological Distress and Financial Burden Impact Adherence to CML Treatment
Read More
Leukemia
Ibrutinib Outperforms Ofatumumab in Patients with Relapsed/Refractory CLL
Read More
Leukemia
Idelalisib Improves Outcomes in Heavily Pretreated Patients with CLL
Read More
Leukemia
Nilotinib Sustains Deeper Molecular Response versus Imatinib in Patients with Ph+ CML
Read More
2
3
4
5
6
7
Page 5 of 7
Results 41 - 50 of 70